Resultats de la cerca - Anouk E. Muller
- Mostrar 1 - 20 resultats de 20
-
1
-
2
-
3
-
4
-
5
Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials per Anouk E. Muller, Els M. Verhaegh, Stephan Harbarth, Johan W. Mouton, Angela Huttner
Publicat 2016Revisão -
6
-
7
-
8
-
9
-
10
-
11
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration per Pierre-François Laterre, Xavier Wittebole, Sébastien Van de Velde, Anouk E. Muller, Johan W. Mouton, Stéphane Carryn, Paul M. Tulkens, Thierry Dugernier
Publicat 2014Artigo -
12
Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome per Birgit C. P. Koch, Anouk E. Muller, Nicole Hunfeld, Brenda C. M. de Winter, Tim M. J. Ewoldt, Alan Abdulla, Henrik Endeman
Publicat 2021Revisão -
13
The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with <i>E. coli</i> and <i>K. pneumoniae</i> per Sanne van den Berg, Sebastiaan D. T. Sassen, William Couet, Sandrine Marchand, Heleen van der Spek, Marian T. ten Kate, Joseph Meletiadis, Anouk E. Muller
Publicat 2025Artigo -
14
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomise... per Alan Abdulla, Tim M. J. Ewoldt, Nicole Hunfeld, Anouk E. Muller, Wim J. R. Rietdijk, Suzanne Polinder, Teun van Gelder, Henrik Endeman, Birgit C. P. Koch
Publicat 2020Artigo -
15
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) per Alan Abdulla, Annemieke Dijkstra, Nicole Hunfeld, Henrik Endeman, Soma Bahmany, Tim M. J. Ewoldt, Anouk E. Muller, Teun van Gelder, Diederik Gommers, Birgit C. P. Koch
Publicat 2020Artigo -
16
Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2... per Wouter van den Bijllaardt, Maarten J. Schijffelen, Ron Bosboom, James Cohen Stuart, B. M. W. Diederen, Greetje A. Kampinga, Thuy-Nga Le, I. T. M. A. Overdevest, F S Stals, Paul Voorn, K. Waar, Johan W. Mouton, Anouk E. Muller
Publicat 2018Artigo -
17
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by t... per Markus Zeitlinger, Birgit C. P. Koch, Roger J. M. Brüggemann, Pieter De Cock, Timothy Felton, Maya Hites, Jennifer Lê, Sònia Luque, Alasdair MacGowan, Deborah Marriott, Anouk E. Muller, Kristina Nadrah, David L. Paterson, Joseph F. Standing, João Paulo Telles, Michael Wölfl‐Duchek, Michaël Thy, Jason A. Roberts
Publicat 2020Revisão -
18
Pharmacokinetics-Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: a Comprehensive Review by t... per Markus Zeitlinger, Birgit C. P. Koch, Roger J. M. Brüggemann, Pieter De Cock, Timothy Felton, Maya Hites, Jennifer Lê, Sònia Luque, Alasdair MacGowan, Deborah Marriott, Anouk E. Muller, Kristina Nadrah, David L. Paterson, Joseph F. Standing, João Paulo Telles, Michael Wölfl‐Duchek, Michaël Thy, Jason A. Roberts
Publicat 2020Revisão -
19
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial per Tim M. J. Ewoldt, Alan Abdulla, Wim J. R. Rietdijk, Anouk E. Muller, Brenda C. M. de Winter, Nicole Hunfeld, Ilse M. Purmer, Peter Van de Vliet, Evert‐Jan Wils, Jasper J. Haringman, Annelies Draisma, Tom A. Rijpstra, Attila Karakus, Diederik Gommers, Henrik Endeman, Birgit C. P. Koch
Publicat 2022Artigo -
20
Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial per M. M. B. Horstink, Dieuwertje R. Geel, Corstiaan A. den Uil, Petronella E. Deetman, Henrik Endeman, Alan Abdulla, Tessa M. Bosch, Wim J. R. Rietdijk, Frederick W. Thielen, Jasper J. Haringman, Peter Van de Vliet, Tom A. Rijpstra, Carina Bethlehem, Albertus Beishuizen, Anouk E. Muller, Birgit C. P. Koch, Chantal A. Boly, Corstiaan A. den Uil, Eva van Haren, Hanneke Buter, Idelette Nutma, J.H. Elderman, L.C.M. Vloet, Mark de Boer, Mathieu van der Jagt, Marcia Kemper, Nicole Gm Hunfeld, Nicole P. Juffermans, Remco C. J. Zwinkels
Publicat 2025Artigo
Eines de cerca:
Matèries relacionades
Medicine
Biology
Microbiology
Antibiotics
Internal medicine
Intensive care medicine
Clinical trial
Pharmacokinetics
Pharmacology
Bacteria
Dosing
Drug
Genetics
Pharmacodynamics
Randomized controlled trial
Antibiotic resistance
Adverse effect
Antibacterial agent
Critically ill
Nitrofurantoin
Virology
Amoxicillin
Anesthesia
Antimicrobial
Antiretroviral therapy
Antiviral drug
Bacterial pneumonia
Biochemistry
Ceftazidime
Cefuroxime